News
The FDA has partially reversed course on its push to halt shipments of a controversial gene therapy made by Sarepta ...
Sarepta shares gained even though the U.S. Food and Drug Administration said late Friday that it was probing the death of an ...
15h
News Nation on MSNParents urge FDA to restore gene therapy after distribution pause
A recent FDA investigation has paused further distribution of Elevidys, following reports of at least three patient deaths.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results